Santen Pharmaceutical Co., Ltd. is a global pharmaceutical company based in Miami, FL, specializing in ophthalmology. With a history of over a century, Santen is committed to enhancing patients' satisfaction and product safety through their medium-term management plan, Santen 2030. They focus on research and development to address untreated patients and offer innovative solutions in the field of ophthalmology. Santen's dedication to sustainability is evident through their efforts in social access to healthcare, environmental initiatives, and inclusive society promotion.
In 2016, Santen acquired InnFocus, Inc., a company that specializes in the development of biomaterials for glaucoma surgery. InnFocus has pioneered the use of SIBS (poly styrene-block-isobutylene-block-styrene), a degradation-resistant biostable polymer, in the creation of implantable products. With a primary focus on glaucoma, InnFocus aims to address unmet needs in the field of ophthalmology and provide effective solutions for patients. Santen's collaboration with InnFocus demonstrates their commitment to advancing ophthalmic healthcare through innovative technologies and partnerships.
Generated from the website